Fig. 3: Cumulative MMR rate in evaluable^a patients who were not in MMR at screening by starting dose.

BID twice daily, IS International Scale, MMR major molecular response (BCR::ABL1^IS ≤ 0.1%); QD once daily. ^aExcluded patients who had atypical or unknown transcripts at screening.